Stockscreener 앱 받기
4.14
1.19%
-0.05
시간 외 거래:
4.16
0.02
+0.48%
전일 마감가:
$4.19
열려 있는:
$4.18
하루 거래량:
204.89K
Relative Volume:
0.33
시가총액:
$91.40M
수익:
-
순이익/손실:
$-94.11M
주가수익비율:
-0.6889
EPS:
-6.01
순현금흐름:
$-86.06M
1주 성능:
-3.50%
1개월 성능:
-7.38%
6개월 성능:
+82.38%
1년 성능:
-28.00%
1일 변동 폭
$4.14
$4.19
1주일 범위
$4.14
$4.2848
52주 변동 폭
$1.78
$6.98
Adverum Biotechnologies Inc Stock (ADVM) Company Profile
명칭
Adverum Biotechnologies Inc
전화
(650) 649-1004
주소
100 CARDINAL WAY, REDWOOD CITY, CA
ADVM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADVM
Adverum Biotechnologies Inc
|
4.14 | 92.50M | 0 | -94.11M | -86.06M | -6.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Adverum Biotechnologies Inc Stock (ADVM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-17 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-06-25 | 개시 | Oppenheimer | Outperform |
| 2024-04-30 | 개시 | H.C. Wainwright | Buy |
| 2022-07-07 | 업그레이드 | Truist | Hold → Buy |
| 2021-07-23 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-05-03 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-04-29 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2021-04-29 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-04-29 | 다운그레이드 | Truist | Buy → Hold |
| 2020-12-16 | 개시 | UBS | Neutral |
| 2020-11-12 | 업그레이드 | Raymond James | Underperform → Mkt Perform |
| 2020-06-26 | 다운그레이드 | Raymond James | Mkt Perform → Underperform |
| 2020-05-13 | 개시 | RBC Capital Mkts | Outperform |
| 2020-05-05 | 업그레이드 | SunTrust | Hold → Buy |
| 2020-04-28 | 개시 | Goldman | Buy |
| 2020-03-16 | 개시 | SVB Leerink | Outperform |
| 2020-02-10 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2020-02-10 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2019-10-15 | 재확인 | Chardan Capital Markets | Neutral |
| 2019-09-13 | 재확인 | Chardan Capital Markets | Neutral |
| 2019-06-14 | 재개 | Raymond James | Mkt Perform |
| 2018-11-02 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2018-11-02 | 다운그레이드 | SunTrust | Buy → Hold |
| 2018-09-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-08-30 | 개시 | SunTrust | Buy |
| 2018-02-15 | 재개 | Piper Jaffray | Overweight |
| 2017-10-12 | 개시 | Raymond James | Outperform |
모두보기
Adverum Biotechnologies Inc 주식(ADVM)의 최신 뉴스
Adverum Biotechnologies Faces Lease Termination Notice - TipRanks
Adverum Biotechnologies IncARE-NC Region No. 21 LLC terminates certain lease agreement with Adverum BiotechnologiesSEC filing - MarketScreener
Chart overlay techniques for tracking Adverum Biotechnologies Inc.2025 Price Targets & Low Risk Growth Stock Ideas - newser.com
Is Adverum Biotechnologies Inc. stock cheap compared to fundamentals2025 Retail Activity & Weekly High Momentum Picks - newser.com
Lilly strengthens gene therapy portfolio with MeiraGTx and Adverum deals - Drug Discovery News
Why Adverum Biotechnologies Inc. stock remains on watchlistsJuly 2025 Levels & Weekly High Conviction Ideas - newser.com
Why Adverum Biotechnologies Inc. (AVU0) stock trades below fair valueJuly 2025 Action & Risk Managed Trade Strategies - newser.com
Will Adverum Biotechnologies Inc. stock maintain growth storyMarket Growth Report & Safe Swing Trade Setups - newser.com
Why retail traders accumulate Adverum Biotechnologies Inc. (AVU0) stockQuarterly Risk Review & Low Drawdown Trading Strategies - newser.com
Has Adverum Biotechnologies Inc. found a price floor2025 Risk Factors & Low Risk High Reward Ideas - newser.com
Volume spikes in Adverum Biotechnologies Inc. stock – what they mean2025 Trading Recap & Real-Time Chart Pattern Alerts - newser.com
Will Adverum Biotechnologies Inc. (AVU0) stock benefit from mergersJuly 2025 Summary & Scalable Portfolio Growth Methods - newser.com
The Zacks Analyst Blog Highlights Eli Lilly, Johnson & Johnson and Adverum - sharewise.com
Published on: 2025-11-19 05:22:39 - newser.com
Will Adverum Biotechnologies Inc. stock deliver consistent dividends2025 Support & Resistance & Long-Term Growth Stock Strategies - newser.com
Published on: 2025-11-18 23:52:15 - newser.com
Why analysts maintain buy rating on Adverum Biotechnologies Inc. (AVU0) stockWatch List & Target Return Focused Picks - newser.com
Halper Sadeh LLC Encourages CMA, ADVM, HOUS Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.
This Yum! Brands Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday - Benzinga
This Alto Neuroscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
HC Wainwright Downgrades Adverum Biotechnologies to Neutral From Buy, Adjusts PT to $5 From $30 - MarketScreener
H.C. Wainwright downgrades Adverum stock to Neutral following Eli Lilly acquisition - Investing.com Canada
This Dell Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday - Benzinga
HC Wainwright Downgrades Adverum Biotechnologies to Neutral From Buy, Price Target is $5 - MarketScreener
Detecting price anomalies in Adverum Biotechnologies Inc. with AIWeekly Stock Analysis & AI Enhanced Market Trend Forecasts - newser.com
Adverum Biotechnologies Inc (ADVM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Adverum Biotechnologies Inc 주식 (ADVM) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER |
May 15 '25 |
Sale |
2.00 |
924 |
1,848 |
13,768 |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR |
May 15 '25 |
Sale |
2.00 |
9,126 |
18,252 |
87,488 |
| Leonard Braden Michael | 10% Owner |
Mar 26 '25 |
Buy |
5.04 |
20,407 |
102,841 |
125,207 |
| Leonard Braden Michael | 10% Owner |
Mar 27 '25 |
Buy |
5.19 |
16,593 |
86,089 |
141,800 |
| Leonard Braden Michael | 10% Owner |
Apr 22 '25 |
Buy |
3.00 |
300,000 |
900,000 |
3,057,526 |
| Leonard Braden Michael | 10% Owner |
Apr 23 '25 |
Buy |
2.98 |
50,000 |
148,950 |
191,800 |
| Leonard Braden Michael | 10% Owner |
Mar 31 '25 |
Buy |
4.38 |
19,566 |
85,668 |
2,742,317 |
| Leonard Braden Michael | 10% Owner |
Apr 02 '25 |
Buy |
4.04 |
15,209 |
61,408 |
2,757,526 |
| Leonard Braden Michael | 10% Owner |
Mar 26 '25 |
Buy |
5.04 |
20,407 |
102,841 |
125,207 |
| Leonard Braden Michael | 10% Owner |
Mar 18 '25 |
Buy |
4.69 |
62,341 |
292,418 |
2,667,161 |
1.38%
1.42%
자본화:
|
볼륨(24시간):